Additionally, it has been observed that the downregulated expression of PTGDR2, PTGDR1, and PTGIR genes was associated with a poorer prognosis in oropharyngeal cancer patients, and all three can be used to screen HPV-ctDNA-negative HPV oropharyngeal cancer patients [89]. This evidence concerns the gene PTGIR and oropharynx cancer.